{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T22:03:32Z","timestamp":1792015412523,"version":"4.4.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002426","name":"Fondazione Telethon","doi-asserted-by":"publisher","award":["GGP09127"],"award-info":[{"award-number":["GGP09127"]}],"id":[{"id":"10.13039\/501100002426","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002426","name":"Fondazione Telethon","doi-asserted-by":"publisher","award":["GGP14144"],"award-info":[{"award-number":["GGP14144"]}],"id":[{"id":"10.13039\/501100002426","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["GR-2010-2309622"],"award-info":[{"award-number":["GR-2010-2309622"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["GR-2016-02363630"],"award-info":[{"award-number":["GR-2016-02363630"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["IG15434"],"award-info":[{"award-number":["IG15434"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.jaci.2019.05.034","type":"journal-article","created":{"date-parts":[[2019,6,10]],"date-time":"2019-06-10T01:43:13Z","timestamp":1560130993000},"page":"368-378.e13","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["A novel knock-in mouse model of cryopyrin-associated periodic syndromes with development of amyloidosis: Therapeutic efficacy of proton pump inhibitors"],"prefix":"10.1016","volume":"145","author":[{"given":"Arinna","family":"Bertoni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Carta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Baldovini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Penco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrica","family":"Balza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Borghini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Di Duca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuela","family":"Ognio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessio","family":"Signori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Nozza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Schena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Castellani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Pastorino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carola","family":"Perrone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Obici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Martini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella","family":"Ceccherini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Gattorno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Rubartelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Chiesa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2019.05.034_bib1","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1038\/ni.3777","article-title":"The monogenic autoinflammatory diseases define new pathways in human innate immunity and inflammation","volume":"18","author":"Manthiram","year":"2017","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaci.2019.05.034_bib2","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1002\/art.37882","article-title":"Beyond the NLRP3 inflammasome: autoinflammatory diseases reach adolescence","volume":"65","author":"Gattorno","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaci.2019.05.034_bib3","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S1074-7613(04)00046-9","article-title":"NALP3 forms an IL-1beta processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder","volume":"20","author":"Agostini","year":"2004","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2019.05.034_bib4","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1182\/blood-2010-07-273417","article-title":"Interleukin-1 in the pathogenesis and treatment of inflammatory diseases","volume":"117","author":"Dinarello","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2019.05.034_bib5","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.tibs.2016.09.002","article-title":"Mechanism and regulation of NLRP3 inflammasome activation","volume":"41","author":"He","year":"2016","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.jaci.2019.05.034_bib6","doi-asserted-by":"crossref","first-page":"8067","DOI":"10.1073\/pnas.0709684105","article-title":"ATP is released by monocytes stimulated with pathogen-sensing receptor ligands and induces IL-1beta and IL-18 secretion","volume":"105","author":"Piccini","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2019.05.034_bib7","doi-asserted-by":"crossref","first-page":"9789","DOI":"10.1073\/pnas.1000779107","article-title":"Altered redox state of monocytes from cryopyrin-associated periodic syndrome causes accelerated IL-1beta secretion","volume":"107","author":"Tassi","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2019.05.034_bib8","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1073\/pnas.1424741112","article-title":"Cell stress increases ATP release in NLRP3 inflammasome-mediated autoinflammatory diseases, resulting in cytokine imbalance","volume":"112","author":"Carta","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2019.05.034_bib9","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1136\/annrheumdis-2012-201340","article-title":"Deficient production of IL-1 receptor antagonist and IL-6 coupled to oxidative stress in cryopyrin associated periodic syndrome monocytes","volume":"71","author":"Carta","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaci.2019.05.034_bib10","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.immuni.2009.05.005","article-title":"Inflammasome-mediated disease animal models reveal roles for innate but not adaptive immunity","volume":"30","author":"Brydges","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2019.05.034_bib11","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.immuni.2009.04.012","article-title":"A mutation in the Nlrp3 gene causing inflammasome hyperactivation potentiates Th17 cell-dominant immune responses","volume":"30","author":"Meng","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2019.05.034_bib12","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.immuni.2009.06.001","article-title":"Knocking in the NLRP3 inflammasome","volume":"30","author":"Girardin","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2019.05.034_bib13","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1586\/1744666X.2015.1077702","article-title":"Current treatment recommendations and considerations for cryopyrin-associated periodic syndrome","volume":"11","author":"Kon\u00e9-Paut","year":"2015","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.jaci.2019.05.034_bib14","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s11926-011-0165-y","article-title":"Current status of understanding the pathogenesis and management of patients with NOMID\/CINCA","volume":"13","author":"Goldbach-Mansky","year":"2011","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.jaci.2019.05.034_bib15","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s00281-015-0491-7","article-title":"CAPS-pathogenesis, presentation and treatment of anautoinflammatory disease","volume":"37","author":"Kuemmerle-Deschner","year":"2015","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.jaci.2019.05.034_bib16","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1586\/eci.10.66","article-title":"Canakinumab: a human anti-IL-1\u03b2 monoclonal antibody for the treatment of cryopyrin-associated periodic syndromes","volume":"6","author":"Church","year":"2010","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.jaci.2019.05.034_bib17","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nm.3806","article-title":"A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases","volume":"21","author":"Coll","year":"2015","journal-title":"Nat Med"},{"key":"10.1016\/j.jaci.2019.05.034_bib18","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1084\/jem.20171419","article-title":"Identification of a selective and direct NLRP3 inhibitor to treat inflammatory disorders","volume":"214","author":"Jiang","year":"2017","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2019.05.034_bib19","first-page":"E1530","article-title":"OLT1177, a \u03b2-sulfonyl nitrile compound, safe in humans, inhibits the NLRP3 inflammasome and reverses the metabolic cost of inflammation","volume":"118","author":"Marchetti","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2019.05.034_bib20","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1007\/s11894-008-0098-4","article-title":"Pharmacology of proton pump inhibitors","volume":"10","author":"Shin","year":"2008","journal-title":"Curr Gastroenterol Rep"},{"key":"10.1016\/j.jaci.2019.05.034_bib21","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jaci.2009.06.023","article-title":"Omeprazole inhibits IL-4 and IL-13 signaling signal transducer and activator of transcription 6 activation and reduces lung inflammation in murine asthma","volume":"124","author":"Cortes","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2019.05.034_bib22","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1007\/s10620-009-0951-9","article-title":"Potential anti-inflammatory effects of proton pump inhibitors: a review and discussion of the clinical implications","volume":"54","author":"Kedika","year":"2009","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jaci.2019.05.034_bib23","doi-asserted-by":"crossref","first-page":"e2304","DOI":"10.1038\/cddis.2016.218","article-title":"Proton pump inhibitors protect mice from acute systemic inflammation and induce long-term cross-tolerance","volume":"7","author":"Balza","year":"2016","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.jaci.2019.05.034_bib24","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1006\/bbrc.1993.2306","article-title":"Evidence for a common binding site for omeprazole and N-ethylmaleimide in subunit A\u00a0of chromaffin granule vacuolar-type H(+)-ATPase","volume":"196","author":"Moriyama","year":"1993","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jaci.2019.05.034_bib25","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s00424-007-0382-4","article-title":"V-ATPase functions in normal and disease processes","volume":"457","author":"Hinton","year":"2009","journal-title":"Pflugers Arch"},{"key":"10.1016\/j.jaci.2019.05.034_bib26","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/cr.2015.68","article-title":"Metabolic reprogramming in macrophages and dendritic cells in innate immunity","volume":"25","author":"Kelly","year":"2015","journal-title":"Cell Res"},{"key":"10.1016\/j.jaci.2019.05.034_bib27","doi-asserted-by":"crossref","first-page":"67482","DOI":"10.18632\/oncotarget.18713","article-title":"Restoring microenvironmental redox and pH homeostasis inhibits neoplastic cell growth and migration: therapeutic efficacy of esomeprazole plus sulfasalazine on 3-MCA-induced sarcoma","volume":"8","author":"Balza","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.jaci.2019.05.034_bib28","doi-asserted-by":"crossref","first-page":"3138","DOI":"10.1002\/art.22842","article-title":"Pattern of interleukin-1beta secretion in response to lipopolysaccharide and ATP before and after interleukin-1 blockade in patients with CIAS1 mutations","volume":"56","author":"Gattorno","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaci.2019.05.034_bib29","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3389\/fimmu.2017.00345","article-title":"Dysregulated IL-1\u03b2 secretionin autoinflammatory diseases: a matter of stress?","volume":"8","author":"Carta","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2019.05.034_bib30","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1136\/annrheumdis-2013-204991","article-title":"Phenotypic and genotypic characteristics of cryopyrin-associated periodic syndrome: a series of 136 patients from the Eurofever Registry","volume":"74","author":"Levy","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaci.2019.05.034_bib31","doi-asserted-by":"crossref","first-page":"e20014","DOI":"10.1371\/journal.pone.0020014","article-title":"Role of IL-1 beta in the development of human T(H)17 cells: lesson from NLPR3 mutated patients","volume":"6","author":"Lasigli\u00e8","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jaci.2019.05.034_bib32","doi-asserted-by":"crossref","first-page":"aad1210","DOI":"10.1126\/science.aad1210","article-title":"T helper 1 immunity requires complement-driven NLRP3 inflammasome activity in CD4\u207a T cells","volume":"352","author":"Arbore","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.jaci.2019.05.034_bib33","doi-asserted-by":"crossref","first-page":"5373","DOI":"10.4049\/jimmunol.1303480","article-title":"TLR costimulation causes oxidative stress with unbalance of proinflammatory and anti-inflammatory cytokine production","volume":"192","author":"Lavieri","year":"2014","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2019.05.034_bib34","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/s41419-018-1121-9","article-title":"Progressive waves of IL-1\u03b2 release by primary human monocytes via sequential activation of vesicular and gasdermin D-mediated secretory pathways","volume":"9","author":"Semino","year":"2018","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.jaci.2019.05.034_bib35","doi-asserted-by":"crossref","first-page":"e3000047","DOI":"10.1371\/journal.pbio.3000047","article-title":"Gasdermin D mediates the pathogenesis of neonatal-onset multisystem inflammatory disease in mice","volume":"16","author":"Xiao","year":"2018","journal-title":"PLoS Biol"},{"key":"10.1016\/j.jaci.2019.05.034_bib36","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1136\/annrheumdis-2011-201268","article-title":"Treatment of autoinflammatory diseases: results from the Eurofever Registry and a literature review","volume":"72","author":"Ter Haar","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaci.2019.05.034_bib37","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1136\/annrheumdis-2013-204877","article-title":"A 24-month open-label study of canakinumab in neonatal-onset multisystem inflammatory disease","volume":"74","author":"Sibley","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaci.2019.05.034_bib38","doi-asserted-by":"crossref","first-page":"4488","DOI":"10.1172\/JCI90699","article-title":"TNF regulates transcription of NLRP3 inflammasome components and inflammatory molecules in cryopyrinopathies","volume":"127","author":"McGeough","year":"2017","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2019.05.034_bib39","doi-asserted-by":"crossref","first-page":"10993","DOI":"10.1074\/jbc.M210328200","article-title":"A novel antioxidant and antiapoptotic role of omeprazole to block gastric ulcer through scavenging of hydroxyl radical","volume":"278","author":"Biswas","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jaci.2019.05.034_bib40","doi-asserted-by":"crossref","first-page":"345","DOI":"10.5414\/CPP45345","article-title":"Suppression of gastric acid with intravenous esomeprazole and omeprazole: results of 3 studies in healthy subjects","volume":"45","author":"R\u00f6hss","year":"2007","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1016\/j.jaci.2019.05.034_bib41","doi-asserted-by":"crossref","first-page":"435","DOI":"10.2165\/00003495-200969040-00004","article-title":"Intravenous proton pump inhibitors: an evidence-based review of their use in gastrointestinal disorders","volume":"69","author":"Bardou","year":"2009","journal-title":"Drugs"},{"key":"10.1016\/j.jaci.2019.05.034_bib42","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.gtc.2010.08.009","article-title":"The safety of drugs used in acid-related disorders and\u00a0functional gastrointestinal disorders","volume":"39","author":"Parikh","year":"2010","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1016\/j.jaci.2019.05.034_bib43","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/ijc.25009","article-title":"pH-dependent antitumor activity of proton pump inhibitors against human melanoma is mediated by inhibition of tumor acidity","volume":"127","author":"De Milito","year":"2010","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jaci.2019.05.034_bib44","doi-asserted-by":"crossref","first-page":"4695","DOI":"10.1172\/JCI71543","article-title":"Divergence of IL-1,IL-18 and cell death in NLRP3 inflammasomopathies","volume":"123","author":"Brydges","year":"2013","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2019.05.034_bib45","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrd1468","article-title":"Drug repositioning: identifying and developing new uses for existing drugs","volume":"3","author":"Ashburn","year":"2004","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jaci.2019.05.034_bibE1","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.immuni.2009.05.005","article-title":"Inflammasome-mediated disease animal models reveal roles for innate but not adaptive immunity","volume":"30","author":"Brydges","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2019.05.034_bibE2","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.immuni.2009.04.012","article-title":"A mutation in the Nlrp3 gene causing inflammasome hyperactivation potentiates Th17 cell-dominant immune responses","volume":"30","author":"Meng","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2019.05.034_bibE3","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1084\/jem.176.6.1693","article-title":"Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte\/macrophage colony-stimulating factor","volume":"176","author":"Inaba","year":"1992","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2019.05.034_bibE4","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0022-1759(98)00204-X","article-title":"An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow","volume":"223","author":"Lutz","year":"1999","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.jaci.2019.05.034_bibE5","doi-asserted-by":"crossref","first-page":"17384","DOI":"10.1073\/pnas.1103650108","article-title":"Mesenchymal stem cells impair in\u00a0vivo T-cell priming by dendritic cells","volume":"108","author":"Chiesa","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2019.05.034_bibE6","doi-asserted-by":"crossref","first-page":"27069","DOI":"10.1074\/jbc.M110.203398","article-title":"The rate of interleukin-1beta secretion in different myeloid cells varies with the extent of redox response to Toll-like receptor triggering","volume":"286","author":"Carta","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jaci.2019.05.034_bibE7","doi-asserted-by":"crossref","first-page":"e2304","DOI":"10.1038\/cddis.2016.218","article-title":"Proton pump inhibitors protect mice from acute systemic inflammation and induce long-term cross-tolerance","volume":"7","author":"Balza","year":"2016","journal-title":"Cell Death Dis"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674919307572?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674919307572?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T09:25:07Z","timestamp":1758792307000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674919307572"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S0091674919307572"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2019.05.034","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel knock-in mouse model of cryopyrin-associated periodic syndromes with development of amyloidosis: Therapeutic efficacy of proton pump inhibitors","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2019.05.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}